Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Maximum_Gain who wrote (3854)	3/5/2000 11:02:00 PM
From: Rich Wolf	Respond to of 4140

Max Gainer, I believe you may have meant 'insightful' when you said to Lipolymer: "Gary, The tone of your response was both refreshing, and <inciteful>. " <ggg> I concur with LiPolymer, that there would still appear to be a large, yet patient, naked short position. My guess is that they are figuring that any number of events could allow them to cover at today's prices, or lower, before the company hits its stride and its stock takes off (assuming it does). Such events would include: a long delay in final FDA approval (my WAG is that the approval comes well before summer); further market weakness that depresses issues across the board; impatience by recent longs (who either were playing for a 'short squeeze' pop or had hoped for movement in the stock by now); or a major stumble by the company. You raise financing vs cash-burn issues as potential stumbling stones. Anecdotal evidence is that there is a backlog of orders for hundreds of the machines already, and since the company has already been ramping up production capacity, and has arranged for independent financing for the customers, SNRS ought to receive cash on the barrelhead once they commence shipping. Looks like a horserace to me: will the shorts get out gently by covering at current market prices, or will they get sideswiped? Just MHO. Regards~!